Eyesight news and eyesight widget

Although there is little evidence to support an association between vision and car accidents, a vision screening law in Florida that targets drivers age 80 and older seems to have reduced the number of adults in this age range who die from motor vehicle collisions. The findings are published in the November issue of Archives of Ophthalmology. "Older drivers represent the fastest-growing segment of the driving population," write Gerald McGwin Jr., M.S., Ph.D.

If a good night's sleep helps the brain and body perform better, it's a good guess that sleep problems can cause more than just fatigue. Numerous studies have shown a connection between sleep disorders and medical conditions such as cardiovascular disease, cerebrovascular disease, and metabolic disorders, including the risk of obesity and diabetes mellitus.

Potentia Pharmaceuticals, a privately held biotechnology company developing medicines for the treatment of age-related macular degeneration (AMD), presented Phase I data last week during the Retina Subspecialty Day at the American Academy of Ophthalmology (AAO) Annual Meeting in Atlanta, GA.

Carl Zeiss Meditec, a leader in complete ophthalmic systems including IOLs and disposables, today announced the newest innovations to its technology offering at the American Academy of Ophthalmology (AAO) meeting in Atlanta, GA. These new systems include diagnostic and surgical applications covering the entire spectrum of patient care and supporting all major segments of ophthalmology, including cataract/refractive, retina and glaucoma.

Nine treatment centres will be established across Wales to help ensure faster, fairer treatment for patients at risk of losing their sight, health Minister Edwina Hart announced today. It follows a review of current arrangements by Local Health Boards for delivering treatment for wet age-related macular degeneration (AMD). Wet AMD is the primary cause of sight loss in the UK.

Potentia Pharmaceuticals, a privately held biotechnology company developing medicines for the treatment of age-related macular degeneration (AMD), presented Phase I data last week during the Retina Subspecialty Day at the American Academy of Ophthalmology (AAO) Annual Meeting in Atlanta, GA.

Today's scientific program of the 2008 Joint Meeting of the American Academy of Ophthalmology (Academy) and European Society of Ophthalmology (SOE) includes a clinical study of a promising new treatment for retinopathy of prematurity (ROP). ROP is often difficult to resolve using current treatments and can result in permanent, severe visual impairment in premature infants when treatment is unsuccessful.

Exposure to prolonged temperature elevation reduces antifungal activity of a contact lens solution that was implicated in the epidemic of the eye infection Fusarium keratitis that occurred between 2004 and 2006, according to a report in the November issue of Archives of Ophthalmology, one of the JAMA/Archives journals.

A vision screening law targeting Florida drivers age 80 and older appears to be associated with lower death rates from motor vehicle collisions in this age group, despite little evidence of an association between vision and car crashes, according to a report in the November issue of Archives of Ophthalmology, one of the JAMA/Archives journals.

If a good night's sleep helps the brain and body perform better, it's a good guess that sleep problems can cause more than just fatigue. Numerous studies have shown a connection between sleep disorders and medical conditions such as cardiovascular disease, cerebrovascular disease, and metabolic disorders, including the risk of obesity and diabetes mellitus.